
8.39 Delayed Data As of May 24 | ![]() Today’s Change | 6.85 Today|||52-Week Range 33.10 | -52.57% Year-to-Date |
Kodiak Sciences (KOD) Q1 Loss Widens, Eye Candidate in Focus May 11 / Zacks.com - Paid Partner Content |
Previous close | 8.34 |
Today’s open | 8.23 |
Day’s range | 7.97 - 8.55 |
Volume | 739,624 |
Average volume (3 months) | 631,769 |
Market cap | $348.0M |
Earnings growth (last year) | +18.15% |
Earnings growth (this year) | -14.11% |
Earnings growth (next 5 years) | +12.20% |
Revenue growth (last year) | +117.19% |
P/E ratio | NM |
Price/Sales | 32.64 |
Price/Book | 1.66 |
Today’s change | Today’s % change | |
---|---|---|
EYPTEyePoint Pharmaceuti... | -0.53 | -5.50% |
ZYMEZymeworks Inc | +0.01 | +0.17% |
---- | ||
ABUSArbutus Biopharma Co... | -0.21 | -8.75% |
Next reporting date | August 29, 2022 |
EPS forecast (this quarter) | -$0.66 |
Annual revenue (last year) | $19.2M |
Annual profit (last year) | -$80.8M |
Net profit margin | -421.89% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |